← All Lantheus Holdings, INC filings

Lantheus Holdings, INC 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

NASDAQ
LNTH
Lantheus Holdings, INC
10-K: Lantheus Navigates Strategic Shifts, Pipeline Progress in 2025
Lantheus Holdings, Inc. reports strategic divestitures, key acquisitions, and pipeline advancements in 2025, alongside leadership changes and PYLARIFY revenue adjustments.
NASDAQ
LNTH
Lantheus Holdings, INC
10-K: Lantheus Holdings Reports Strong 2024 Results, Expands Pipeline with Strategic Acquisitions
Lantheus Holdings' 2024 10-K filing highlights strategic acquisitions, revenue growth driven by PYLARIFY and DEFINITY, and ongoing clinical development programs.
NASDAQ
LNTH
Lantheus Holdings, INC
10-K: Lantheus Holdings Reports Strong 2023 Results, Navigates Leadership Transition and Strategic Partnerships
Lantheus Holdings announces a CEO succession plan, strategic agreements with Perspective Therapeutics, and positive topline results for PNT2002, while navigating a complex regulatory and competitive landscape.